IDEAYA Biosciences, Inc. Common Stock (IDYA) is a publicly traded Healthcare sector company. As of October 16, 2026, IDYA trades at $33.83 with a market cap of $3.27B and a P/E ratio of -18.92. IDYA moved -0.07% today. Year to date, IDYA is +0.00%; over the trailing twelve months it is +19.27%. Its 52-week range spans $13.45 to $42.68. Analyst consensus is strong buy with an average price target of $54.44. Rallies surfaces IDYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IDYA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IDYA recently traded at $33.83. Market cap is $3.27B. P/E ratio is -18.92. Revenue is $234.13M.
| Metric | Value |
|---|---|
| Price | $33.83 |
| Market Cap | $3.27B |
| P/E Ratio | -18.92 |
| EPS | $-1.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.68 |
| 52-Week Low | $13.45 |
| Volume | 48 |
| Avg Volume | 0 |
| Revenue (TTM) | $234.13M |
| Net Income | $-175.02M |
| Gross Margin | 0.00% |
10 analysts cover IDYA: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.44.